ProfileGDS4459 / ENSG00000198755
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 97% 92% 97% 97% 97% 94% 96% 95% 96% 94% 96% 94% 97% 97% 95% 96% 89% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 18.8197
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 27.4992
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 38.897
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 48.6797
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 58.7997
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 68.0994
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 78.4596
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 88.3695
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 98.4596
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 107.9694
GSM623474group B, liver allograft wedge biopsie placebo treatment 18.5696
GSM623475group B, liver allograft wedge biopsie placebo treatment 28.1694
GSM623476group B, liver allograft wedge biopsie placebo treatment 38.6297
GSM623477group B, liver allograft wedge biopsie placebo treatment 48.7297
GSM623478group B, liver allograft wedge biopsie placebo treatment 58.3495
GSM623479group B, liver allograft wedge biopsie placebo treatment 68.6596
GSM623480group B, liver allograft wedge biopsie placebo treatment 77.189